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background: Heterotaxy syndromes of asplenia and polysplenia encompass a wide spectrum of complex cardiovascular abnormalities associated 
with left-right asymmetry. The combination of structural and electrical cardiac abnormalities along with extracardiac co-morbidity makes cardiac 
surgery in heterotaxy syndrome challenging and associated with high morbidity and mortality. We report the mortality after cardiac surgery in 
patients with heterotaxy from the Pediatric Cardiac Care Consortium (PCCC).
methods: We identified 1,169 patients with a diagnosis of heterotaxy that underwent cardiac operation in a PCCC center between 1982 and 2005.
results: 753 (64.4%) had asplenia and 416 (35.6%) polysplenia. Detailed results are presented in the following table.
A. Initial Procedure
Asplenia Polysplenia
n Mortality n Mortality
Aorto-Pulmonary shunt 375 17% 114 13.20%
Pulmonary band 25 28% 21 38.10%
Glenn shunt 44 9.10% 18 0.00%
Fontan 8 37.50% 11 27.30%
Total anomalous pulmonary venous return repair 157 47% 17 23.50%
Pacemaker 8 25% 30 46.7%
Miscellaneous* 136 13.4% 205 24.50%
Total 753 27.8% 416 30.5%
B. Subsequent Procedures
Asplenia Polysplenia
n Mortality n Mortality
Aorto-Pulmonary shunt 110 10.90% 34 0%
Glenn shunt 257 5.80% 92 5.40%
Fontan 274 15.30% 97 9.30%
Total anomalous pulmonary venous return repair 45 24.40%
Miscellaneous* 233 6.9% 116 6.9%
Total 919 11.6% 339 6.3%
C. Accumulative outcomes after 1st and subsequent procedures
Asplenia Polysplenia All Heterotaxy
n (total patients) 753 416 1,169
n1 (survivors 1st procedure) 543 (72.1%) 289 (69.5%) 832 (71.2%)
n2 (survivors subsequent procedure) 480 (63.7%) 272 (70.4%) 752 (66.3%)
Univentricular palliation (% of n1) 232 89 321
Cardiac transplantation 20 (2.7%) 13 (3.1%) 33 (2.8%)
Pacemaker/AICD 65 (8.7%) 89 (21.4%) 154 (13.2%)
Overall mortality 267 (35.8%) 114 (27.4%) 381 (32.6%)
*Miscellaneous procedures include: atrioventricular valve repair, closure of atrial or ventricular septal defects, augmentation of the aorta and others.
conclusion: Our results illustrate a high overall surgical mortality (32.6%) in patients with heterotaxy syndrome (35.9% in asplenia and 27.4% in 
polysplenia). Univentricular palliation occurs frequently in asplenia (48.3%) than polysplenia (32.7%) survivors (p<0.01). Pacemaker implantation 
occur in 1% of the asplenia and 7% in polysplenia (p<0.0001) with significant mortality (25% and 46.7% respectively).
